MTLRP genetic polymorphism (214C>A) was associated with Type 2 diabetes in Caucasian population: A meta-analysis

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Chen, Li Li ^a   Han, Song Mei ^a   Tang, Fei Fei ^a   Li, Qiang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; MTLRP; Polymorphism; Type 2 diabetes

Indexed keywords

GHRELIN; MTLRP PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CAUCASIAN; CLINICAL TRIAL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GHRELIN; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84907971955     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-124     Document Type: Article

References (25)

1. Global estimates of the prevalence of diabetes for 2010 and 2030. Shaw JE, Sicree RA, Zimmet PZ, Diabetes Res Clin Pract 2010 87 4 14 10.1016/j.diabres.2009.10.007 19896746
2. Economic costs of diabetes in the U.S. in 2012. American Diabetes Association, Diabetes Care 2013 36 1033 1046 23468086
3. Global healthcare expenditure on diabetes for 2010 and 2030. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G, Diabetes Res Clin Pract 2010 87 293 301 10.1016/j.diabres.2010.01.026 20171754
4. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes. Dailey G, Clin Ther 2011 33 665 678 10.1016/j.clinthera.2011.04.025 21704233
5. Genetic epidemiology of type 2 diabetes and cardiovascular diseases in Africa. Tekola-Ayele F, Adeyemo AA, Rotimi CN, Prog Cardiovasc Dis 2013 56 251 260 10.1016/j.pcad.2013.09.013 24267432
6. Association of genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus. Abbas S, Raza ST, Ahmed F, Ahmad A, Rizvi S, Mahdi F, J Biomed Sci 2013 20 80 10.1186/1423-0127-20-80 24156506
7. A role for ghrelin in the central regulation of feeding. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S, Nature 2001 409 194 198 10.1038/35051587 11196643
8. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Kojima M, Hosoda H, Matsuo H, Kangawa K, Trends Endocrinol Metab 2001 12 118 122 10.1016/S1043-2760(00)00362-3 11306336
9. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S, Diabetes 2002 51 124 129 10.2337/diabetes.51.1.124 11756331
10. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M, J Clin Endocrinol Metab 2002 87 2988 2991 10.1210/jcem.87.6.8739 12050285
11. Ghrelin strongly stimulates growth hormone release in humans. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K, J Clin Endocrinol Metab 2000 85 4908 4911 10.1210/jcem.85.12.7167 11134161
12. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Lawrence CB, Snape AC, Baudoin FM, Luckman SM, Endocrinology 2002 143 155 162 10.1210/endo.143.1.8561 11751604
13. Ghrelin induces adiposity in rodents. Tschfp M, Smiley DL, Heiman ML, Nature 2000 407 908 913 10.1038/35038090 11057670
14. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I, Diabetes 2001 50 2438 2443 10.2337/diabetes.50.11.2438 11679419
15. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye Z, Nargund RP, Smith RG, Van der Ploeg LH, Howard AD, MacNeil DJ, Qian S, Endocrinology 2004 145 2607 2612 10.1210/en.2003-1596 14962995
16. Association between the ghrelin Leu72Met polymorphism and type 2 diabetes risk: a meta-analysis. Liao N, Xie ZK, Huang J, Xie ZF, Gene 2013 517 179 183 10.1016/j.gene.2012.12.094 23321590
17. Relationship between Ghrelin gene Ar951Gln and Leu72Met polymorphism and Type 2 diabetes and blood lipids levels in Hui population. Zhang SL, Liu J, Guo Q, Liu X, Lanzhou Univ J Med Ed 2011 37 21 24
18. Association of ghrelin gene polymorphism with type 2 diabetes and lipid metabolism in Dongxiang, Hui and Han population. Liu J, Liu J, Zhang SL, Zhang YL, Liu JX, Guo Q, Bing YJ, Wang YF, Chi J Diabetes 2012 4 290 295
19. Correlation between Ghrelin gene polymorphism and type 2 diabetes. Xu LL, Xiang HD, Preclinic Clin 2008 28 44 47
20. The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes. Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I, Clin Chim Acta 2009 399 112 116 10.1016/j.cca.2008.09.022 18848536
21. Association of ghrelin Leu72Met polymorphism with type 2 diabetes mellitus in Chinese population. Liu J, Liu J, Tian LM, Liu JX, Bing YJ, Zhang JP, Wang YF, Zhang LY, Gene 2012 504 309 312 10.1016/j.gene.2012.03.025 22441120
22. Polymorphisms in the ghrelin gene are associated with serum high-density lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans. Choi HJ, Cho YM, Moon MK, Choi HH, Shin HD, Jang HC, Kim SY, Lee HK, Park KS, J Clin Endocrinol Metab 2006 91 4657 4663 10.1210/jc.2005-2549 16954159
23. Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Kim SY, Jo DS, Hwang PH, Park JH, Park SK, Yi HK, Lee DY, Metabolism 2006 55 366 370 10.1016/j.metabol.2005.09.011 16483881
24. Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes. Larsen LH, Gjesing AP, Sørensen TI, Hamid YH, Echwald SM, Toubro S, Black E, Astrup A, Hansen T, Pedersen O, Clin Biochem 2005 38 420 424 10.1016/j.clinbiochem.2005.01.008 15820771
25. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes. Garcia EA, King P, Sidhu K, Ohgusu H, Walley A, Lecoeur C, Gueorguiev M, Khalaf S, Davies D, Grossman AB, Kojima M, Petersenn S, Froguel P, Korbonits M, Eur J Endocrinol 2009 161 307 315 10.1530/EJE-09-0122 19460888